MedPath

Effect of Vitamin C on pediatrics urinary tract infectio

Phase 2
Conditions
NO39.0
rinary tract infection.
Urinary tract infection, site not specified
Registration Number
IRCT2015073113366N5
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
152
Inclusion Criteria

the positive urinary tract infection; absence of congenital kidney disease and consent to participate in research project. Exclusion criteria: any reason patients want to leave the study and not satisfied to use their personal data in the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rinary tract infection. Timepoint: Before and after drug consumption which is in a period of 14 days. Method of measurement: Urine culture.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath